Orthopedic Biomaterials Market Report Suite - India - 2020 - 2026 - MedSuite

Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring

2.1 INTRODUCTION
2.2 PRODUCT PORTFOLIOS
2.2.1 Bone Graft Substitutes
2.2.2 Growth Factors
2.2.2.1 Other Products
2.2.3 Hyaluronic Acid Viscosupplementation (HAV)
2.3 REGULATORY ISSUES AND RECALLS
2.3.1 Bone Graft Substitutes
2.3.1.1 Allografts
2.3.1.1.1 MTF
2.3.1.2 DBM
2.3.1.2.1 AlloSource
2.3.1.2.2 SeaSpine
2.3.1.2.3 RTI Surgical
2.3.1.3 Synthetics
2.3.1.3.1 Abyrx
2.3.1.3.2 Zimmer Biomet
2.3.2 Growth Factors
2.3.2.1.1 Medtronic
2.3.3 Hyaluronic Acid Viscosupplementation
2.3.3.1 Three-injection
2.3.3.1.1 Ferring Pharmaceuticals
2.4 CLINICAL TRIALS
2.4.1 Bone Graft Substitutes
2.4.1.1 Allografts
2.4.1.1.1 Providence Medical Technology
2.4.1.1.2 The University of Texas Health Science
2.4.1.1.3 University of Winchester
2.4.1.2 BDM
2.4.1.2.1 K2M
2.4.1.2.2 Zimmer Biomet
2.4.1.3 Synthetics
2.4.1.3.1 Baxter
2.4.1.3.2 Bonesupport
2.4.1.3.3 DePuy Synthes
2.4.1.3.4 NuVasive
2.4.1.3.5 RTI surgical
2.4.1.3.6 Sunstar GUIDOR
2.4.1.4 Other materials and comparison
2.4.1.4.1 Seoul National University Hospital.
2.4.1.4.2 Sewon Cellontech
2.4.1.4.3 SurgaColl Technologies Limited
2.4.1.4.4 University of Colorado
2.4.1.4.5 University of Padova
2.4.2 Growth Factors
2.4.2.1.1 Bioventus
2.4.2.1.2 Cerapedics
2.4.2.1.3 CGBio
2.4.2.1.4 Isto
2.4.2.1.5 Medtronic
2.4.2.1.6 NuVasive
2.4.2.1.7 Wright
2.4.2.1.8 Others
2.4.3 Hyaluronic Acid Viscosupplementation
2.4.3.1.1 Anika Therapeutics
2.4.3.1.2 Bioventus
2.4.3.1.3 Cairo University
2.4.3.1.4 Ferring Pharmaceuticals
2.4.3.1.5 Federal University of Minas Gerais
2.4.3.1.6 Fidia Pharma USA Inc.
2.4.3.1.7 Istituto Ortopedico Rizzoli
2.4.3.1.8 University Hospital
2.4.3.1.9 Universidade Nova de Lisboa

3.1 INTRODUCTION
3.1.1 Bone Graft Substitutes
3.1.2 Growth Factors
3.1.3 Hyaluronic Acid (HA) Viscosupplementation
3.2 CURRENCY EXCHANGE RATE
3.3 MARKET OVERVIEW AND TREND ANALYSIS
3.4 DRIVERS AND LIMITERS
3.4.1 Market Drivers
3.4.2 Market Limiters
3.5 COMPETITIVE MARKET SHARE ANALYSIS
3.6 MERGERS AND ACQUISITIONS
3.7 COMPANY PROFILES
3.7.1 Anika Therapeutics
3.7.2 Bioventus
3.7.3 DePuy Synthes
3.7.4 Ferring Pharmaceuticals
3.7.5 Fidia Pharmaceuticals
3.7.6 Genzyme (Sanofi Group)
3.7.7 Harvest Technologies (Terumo BCT)
3.7.8 Integra LifeSciences
3.7.9 Medtronic
3.7.10 Musculoskeletal Transplant Foundation (MTF)
3.7.11 NuVasive
3.7.12 Orthofix
3.7.13 RTI Surgical
3.7.14 Stryker
3.7.15 Vericel Corporation (formerly Aastrom Bioscience)
3.7.16 Zimmer Biomet
3.8 SWOT ANALYSIS
3.8.1 Anika Therapeutics
3.8.2 Bioventus
3.8.3 DePuy Synthes
3.8.4 Ferring Pharmaceuticals
3.8.5 Fidia Pharmaceuticals
3.8.7 Harvest Technologies (Terumo BCT)
3.8.8 Integra LifeSciences
3.8.9 Medtronic
3.8.10 Musculoskeletal Transplant Foundation (MTF)
3.8.11 NuVasive
3.8.12 Orthofix
3.8.14 Stryker
3.8.15 Vericel Corporation (formerly Aastrom Bioscience)
3.8.16 Zimmer Biomet

4.1 INTRODUCTION
4.1.1 Units per Procedure by Indication
4.2 PROCEDURES
4.2.1 Orthopedic Biomaterial Procedures by Segment
4.2.2 Orthopedic Bone Grafting Procedures
4.2.2.1 Orthopedic Bone Grafting Procedures by Material
4.2.2.1.1 Autograft Procedures by Indication
4.2.2.1.2 Allograft Procedures by Indication
4.2.2.1.3 DBM Allograft Procedures by Indication
4.2.2.1.4 Synthetic Procedures by Indication
4.2.2.2 Orthopedic Bone Grafting Procedures by Indication
4.2.3 Orthopedic Growth Factor Procedures
4.2.4 Hyaluronic Acid Supplementation Procedures
4.2.4.1 Hyaluronic Acid Supplementation Procedures by Injection Cycle

5.1 INTRODUCTION
5.2 MARKET OVERVIEW
5.2.1 Orthopedic Bone Graft Substitute Market by Material
5.2.2 Orthopedic Bone Graft Substitute Market by Indication
5.3 MARKET ANALYSIS AND FORECAST
5.3.1 Total Orthopedic Bone Graft Substitute Market
5.3.2 Orthopedic Bone Graft Substitute Market by Material
5.3.2.1 Allograft Bone Graft Substitute Market
5.3.2.1.1 Allograft Bone Graft Substitute Market by Indication
5.3.2.2 Demineralized Bone Matrix Allograft Bone Graft Substitute Market
5.3.2.2.1 Demineralized Bone Matrix Allograft Bone Graft Substitute Market by Indication
5.3.2.3 Synthetic Bone Graft Substitute Market
5.3.2.3.1 Synthetic Bone Graft Substitute Market by Indication
5.3.3 Orthopedic Bone Graft Substitute Market by Indication
5.3.3.1 Spine Bone Graft Substitute Market
5.3.3.2 Cervical Spine Bone Graft Substitute Market
5.3.3.3 Thoracolumbar Spine Bone Graft Substitute Market
5.3.3.4 Trauma Bone Graft Substitute Market
5.3.3.5 Non-Union Trauma Bone Graft Substitute Market
5.3.3.6 Fresh Fracture Trauma Bone Graft Substitute Market
5.3.3.7 Large Joint Reconstruction Bone Graft Substitute Market
5.3.3.8 Hip Reconstruction Bone Graft Substitute Market
5.3.3.9 Knee Reconstruction Bone Graft Substitute Market
5.3.3.10 Foot Reconstruction Bone Graft Substitute Market
5.3.3.11 Craniomaxillofacial Bone Graft Substitute Market
5.3.3.12 Oncology Bone Graft Substitute Market
5.4 DRIVERS AND LIMITERS
5.4.1 Market Drivers
5.4.2 Market Limiters
5.5 COMPETITIVE MARKET SHARE ANALYSIS

6.1 INTRODUCTION
6.1.1 BMP-2 (Medtronic)
6.2 MARKET ANALYSIS AND FORECAST
6.3 DRIVERS AND LIMITERS
6.3.1 Market Drivers
6.3.2 Market Limiters
6.4 COMPETITIVE MARKET SHARE ANALYSIS

7.1 INTRODUCTION
7.1.1 Benefits of Viscosupplementation
7.1.2 Synovial Fluid
7.2 MARKET OVERVIEW
7.3 MARKET ANALYSIS AND FORECAST
7.3.1 Total Hyaluronic Acid Viscosupplementation Market
7.3.2 Single-Injection Hyaluronic Acid Viscosupplementation Market
7.3.3 Three-Injection Hyaluronic Acid Viscosupplementation Market
7.3.4 Five-Injection Hyaluronic Acid Viscosupplementation Market
7.4 DRIVERS AND LIMITERS
7.4.1 Market Drivers
7.4.2 Market Limiters
7.5 COMPETITIVE MARKET SHARE ANALYSIS